Earlier studies reported that VEGFR2-mediated activation of the PAM signaling pathway is essential for tumor survival, and Myricetin is known to inhibit the growth of breast tumor cells by regulating VEGF (23, 48, 49). Here, KDR is linked to neoplasm.